Actual practice in hypertension: Implications for persistence with and effectiveness of therapy

Current Hypertension Reports

Volumn 3, Issue 6, 2001, Pages 481-487

  Spence, Jeffrey D ^a   Hurley, Thomas C ^a   Spence, J David ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; PHYSIOLOGY; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; GUIDELINE ADHERENCE; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035653537     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-001-0010-1     Document Type: Article

References (31)

1. Joffres MR, Ghadirian P, Fodor J.G., et al.: Awareness, treatment and control of hypertension in Canada. Am J Hypertens 1997, 10: 1097-1102.
2. Spence JD: Physiologic tailoring of therapy for resistant hypertension: 20 year' experience with stimulated renin profiling. Am J Hypertens 1999, 12:1077-1083.
3. Campbell NRC, Burgess ED, Choi BCK, et al.: Lifestyle Modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Can Med Assoc J 1999, 160(9 Suppl): S1-S12.
4. Tsuyuki RT, Bungard TJ: Poor adherence with hypolipidemic drugs: a lost opportunity. Pharmacotherapy 2001, 21: 576-582.
5. Ontario Guidelines for the treatment of Uncomplicated Hypertension. Toronto: Ministry of Health of Ontario; 1995.
6. Carruthers SG, Larochelle P, Haynes R.B., et al.: Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction. Can Med Assoc J 1993, 149:289-293.
7. Ogilvie RI, Burgess ED, Cusson J.R., et al.: Report of the Canadian Hypertension Society Consensus Conference: 3. Phar-macologic treatment of essential hypertension. Can Med Assoc J 1993, 149:575-584.
8. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) [see comments]. Arch Intern Med 1993, 153:154-183.
9. Myers MG, Carruthers SG, Leenen F.H., et al.: Recommendations from the Canadian Hypertension Society consensus conference on the pharmacologic treatment of hypertension. Can Med Assoc J 1989, 140:1141-1146.
10. Collins R, Peto R, McMahon S., et al.: Blood pressure, stroke and coronary artery disease. Lancet 1990, 335:827-838.
11. Bulletin of the Drug Quality & Therapeutics Committee of Ontario. Toronto: Drug Programs Branch, Ministry of Health; 1994.
12. SHEP Cooperative Research Group: Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255-3264.
13. Scandinavian Simvastatin Survival Study Group: Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994, 344:1383-1389.
14. Goldman L, Weinstein MC, Goldman P.A., et al.: Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA 1991, 265:1145-1151.
15. MRC Working Party: Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992, 304:405-412.
16. Beto JA, Bansal VK: Quality of life in treatment of hypertension: a meta-analysis of clinical trials. Am J Hypertens 1992, 5:125-133.
17. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997, 157:2413-2446.
18. Cohen JS: Adverse drug effects, compliance, and initial doses of antihypertensive drugs recommended by the Joint National Committee vs the Physicians' Desk Reference. Arch Intern Med 2001, 161:880-885.
19. Neutel JM, Smith DHG, Weber MA: Low-dose combination therapy: an important first-line treatment in the management of hypertension. Am J Hypertens 2001, 14:286-292.
20. Khoo KL, Liew YM, Tan H, et al: Patients' knowledge and attitude towards treatment and control of hypertension: a nation-wide telephone survey conducted in Malaysia. Med J Malaysia 1999, 54:37-46.
21. Shaw E, Anderson JG, Maloney M, et al: Factors associated with noncompliance of patients taking antihypertensive medications. Hosp Pharm 1995, 30:201-207.
22. Caro JJ, Speckman JL, Salas M, et al: Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. Can Med Assoc J 1999, 160:41-46.
23. Caro JJ, Salas M, Speckman J.L., et al.: Persistence with treatment for hypertension in actual practice. Can Med Assoc J 1999, 160:31-37.
24. Bloom BS: Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998, 20:1-11.
25. Boccuzzi SJ, Fox J, Roehm J.B., et al.: Angiotensin II antagonists demonstrate greater long-term persistence versus other antihypertensive medications. Am J Hypertens 2001, 14:A10.
26. Moore MA, Edelman JM, Gazdick L.P., et al.: Choice of initial antihypertensive medication may influence the extent to which patients stay on therapy: a community-based study of a losartan-based regimen vs. usual care. High Blood Press Car-diovasc Prevent 1998, 7:156.
27. Zarnke KB, Marentette MA, Gerth WC: Saskatchewan Health Database analysis of antihypertensive persistence. Paper presented at 2nd International Forum on Angiotensin Antagonists. Monte Carlo. January, 2001.
28. Hughes D, McGuire A: The direct costs to the NHS of discontinuing and switching prescriptions for hypertension. J Hum Hypertens 1998, 12:533-537.
29. Coons SJ, Sheahan SL, Martin S.S., et al.: Predictors of medication noncompliance in a sample of older adults. Clin Ther 1994, 16:110-117.
30. Chen JG, Smith RD, Gerth W.C., et al.: Effect of antihypertensive treatment on utilization of acute care services. Am J Hypertens 2001, 14:A23.
31. Tamblyn R, Laprise R, Hanley J.A., et al.: Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001, 285:421-429.